Data collection

Patient assessment

Enter the hospital ID first. Existing patients are recognised automatically — this visit is then added to their record so parameters can be tracked chronologically.

Hospital / centre

Hospital ID

Visit label

Visit date

Biodata

Name

Age (years)

Sex

Type of cancer, staging

Cancer status (this visit)

Resting blood pressure (mmHg)

Anthracycline already received elsewhere (mg/m² doxorubicin-equiv, not otherwise on file)

RT mean heart dose already received elsewhere (Gy, not otherwise on file)

Comorbidities

Functional status — ECOG performance status

QTc calculator

Computes QTc (Bazett) from measured QT plus either heart rate or a directly-measured RR interval, and fills it into the ECG section's QTc field automatically as you type. If both HR and RR are entered, RR interval takes precedence. A manually entered ECG QTc is never overwritten.

Heart rate (bpm)

or RR interval (ms)

Measured QT (ms)

Baseline cardiac status

Tap a modality to enter its values. Collapsed sections are skipped, not cleared — enter only what was actually done.

hs-Troponin (ng/L)

NT-proBNP (pg/mL)

Symptomatic heart failure at this visit? (ESC 2022 CTRCD symptomatic grading)

Drives the CTRCD severity grade below, which can auto-escalate risk category and surveillance intensity for this patient.

Heart-failure (cardioprotective) medications

Tick any of the four pillar classes already started for this patient. Start date/time is captured automatically the first time a class is ticked, and carried forward on later visits — edit the dose as it's titrated.

Proposed / planned cancer therapy

Type a drug name to identify its class automatically, or tick classes directly below. Unrecognised drugs are added to a generic surveillance bucket so nothing is left unmonitored.

Chemotherapy / targeted-therapy drug name

Treatment regimen (optional)

Pick a named regimen (e.g. R-CHOP). Specific drugs are auto-listed for you to cross-check; classes are ticked. The regimen name and drug list are saved and recalled on follow-up visits.

Type to search

Current cycle # (only if patient is already mid-course)

Leave blank for a patient starting therapy now. If they're already partway through — including a first visit here for a patient already receiving treatment elsewhere — enter their current cycle number: it sets the correct "due now" column directly (more precise than guessing from dates) and automatically extends the surveillance chart if this cycle is beyond what's normally shown.

Cycle length (days)

Used only to project an actual calendar date for the next cycle-based test (e.g. "next biomarker panel due ~14 Oct"). Defaults to 21 days (the most common regimen interval) — change it if this regimen differs.

Drug not in the list?

Save it with a class and monitoring note so it's identified automatically next time.

Drug name

Class

Monitoring / cardiotoxicity note (optional)

If radiotherapy planned — mean heart dose (Gy)

Cumulative mean heart dose is tracked automatically across this patient's visits and flagged at 10 / 15 Gy.

Records

Patient records

Saved on this device. Visits sync to the admin server as you save them; use the lookup below to pull in a record entered on another device.

Search patients (this device)

Not showing up above? Pull a record from the admin server

For a patient entered on a different device that hasn't shown up here yet.

Browse everyone on the admin server

On demand only — needs the staff access code (ask your admin), separate from their password.

Dashboard

Due for surveillance

Patients flagged by an estimated interval based on their highest confirmed risk level at last visit. A general fallback — not a substitute for the agent-specific schedule on each patient's own record.

Research

Cohort trends & data recovery

Pull every recorded value for a parameter across patients, filtered by drug or drug class, for trend review or export to external statistics software.

Parameter

Drug class

Specific drug name (optional)

Patient (optional)

Risk category (any visit)

LVEF trajectory

Reference

HFA–ICOS baseline risk table & surveillance protocols

The full point-scoring table and per-agent surveillance schedules this tool applies, for review offline. Source: 2022 ESC Cardio-Oncology Guidelines (HFA-ICOS), local cardio-oncology SOP.